Surprise Me!

FDA Grants Moderna's COVID-19 Vaccine Full Approval

2022-01-31 305 Dailymotion

FDA Grants Moderna's, COVID-19 Vaccine , Full Approval.<br />On January 31, Moderna announced that its <br />COVID-19 vaccine has been granted full approval <br />by United States health regulators. .<br />On January 31, Moderna announced that its <br />COVID-19 vaccine has been granted full approval <br />by United States health regulators. .<br />The Associated Press reports that since its <br />emergency authorization over a year ago, the vaccine <br />has already been given to tens of millions of Americans. .<br />The Associated Press reports that since its <br />emergency authorization over a year ago, the vaccine <br />has already been given to tens of millions of Americans. .<br />In August of 2021, the FDA granted <br />full approval to Pfizer's vaccine.<br />The Associated Press reports that over <br />211 million Americans are fully vaccinated -<br />about 63% of the population. .<br />The Associated Press reports that over <br />211 million Americans are fully vaccinated -<br />about 63% of the population. .<br />Approximately 86 million people have <br />received at least one dose of a booster. .<br />According to the AP, vaccinations peaked at over <br />3 million doses were distributed per day last spring.<br />Now, daily doses average less than 750,000. .<br />The AP reports that the vaccine's initial <br />emergency approval was based on a study <br />that tracked 44,000 people for two months.<br />Moderna then continued that study <br />to complete longer six-month-long studies <br />normally required for full approval. .<br />The FDA reportedly monitored for serious side effects that have proven to be extremely rare. .<br />The FDA reportedly monitored for serious side effects that have proven to be extremely rare. .<br />Last fall, the FDA delayed approving Moderna's <br />vaccine for use in 12 to 17 year olds as it investigated <br />the risk of heart inflammation in young men. .<br />Last fall, the FDA delayed approving Moderna's <br />vaccine for use in 12 to 17 year olds as it investigated <br />the risk of heart inflammation in young men.

Buy Now on CodeCanyon